These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 20633921)
1. Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population. Ingelido AM; Marra V; Abballe A; Valentini S; Iacovella N; Barbieri P; Porpora MG; Domenico Ad; De Felip E Chemosphere; 2010 Aug; 80(10):1125-30. PubMed ID: 20633921 [TBL] [Abstract][Full Text] [Related]
2. Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: preliminary results of the PREVIENI project. La Rocca C; Alessi E; Bergamasco B; Caserta D; Ciardo F; Fanello E; Focardi S; Guerranti C; Stecca L; Moscarini M; Perra G; Tait S; Zaghi C; Mantovani A Int J Hyg Environ Health; 2012 Feb; 215(2):206-11. PubMed ID: 22197512 [TBL] [Abstract][Full Text] [Related]
3. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Midasch O; Schettgen T; Angerer J Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899 [TBL] [Abstract][Full Text] [Related]
4. Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid. Hsu JY; Hsu JF; Ho HH; Chiang CF; Liao PC Chemosphere; 2013 Sep; 93(3):532-7. PubMed ID: 23886440 [TBL] [Abstract][Full Text] [Related]
5. Current exposure of Italian women of reproductive age to PFOS and PFOA: A human biomonitoring study. De Felip E; Abballe A; Albano FL; Battista T; Carraro V; Conversano M; Franchini S; Giambanco L; Iacovella N; Ingelido AM; Maiorana A; Maneschi F; Marra V; Mercurio A; Nale R; Nucci B; Panella V; Pirola F; Porpora MG; Procopio E; Suma N; Valentini S; Valsenti L; Vecchiè V Chemosphere; 2015 Oct; 137():1-8. PubMed ID: 25965289 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of perfluorooctane sulfonate and perfluorooctane acid in serum of non-occupational human from Shenyang and Chongqing areas]. Jin YH; Dong GH; Shu WQ; Ding M; Zhai C; Wang L; Liu X; Saitou N; Sasaki K Wei Sheng Yan Jiu; 2006 Sep; 35(5):560-3. PubMed ID: 17086703 [TBL] [Abstract][Full Text] [Related]
7. Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid. Thompson J; Lorber M; Toms LL; Kato K; Calafat AM; Mueller JF Environ Int; 2010 May; 36(4):390-397. PubMed ID: 20236705 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of perfluorooctanoic acid and perfluorooctanesulfonic acid in Korean sera using LC-MS/MS. Heo DG; Lee DC; Kwon YM; Seol MJ; Moon JS; Chung SM; Kim JH J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123138. PubMed ID: 35114474 [TBL] [Abstract][Full Text] [Related]
9. Hazard quotient profiles used as a risk assessment tool for PFOS and PFOA serum levels in three distinctive European populations. Ludwicki JK; Góralczyk K; Struciński P; Wojtyniak B; Rabczenko D; Toft G; Lindh CH; Jönsson BA; Lenters V; Heederik D; Czaja K; Hernik A; Pedersen HS; Zvyezday V; Bonde JP Environ Int; 2015 Jan; 74():112-8. PubMed ID: 25454227 [TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study. Tanner EM; Bloom MS; Wu Q; Kannan K; Yucel RM; Shrestha S; Fitzgerald EF Int Arch Occup Environ Health; 2018 Feb; 91(2):145-154. PubMed ID: 29027000 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Fromme H; Midasch O; Twardella D; Angerer J; Boehmer S; Liebl B Int Arch Occup Environ Health; 2007 Feb; 80(4):313-9. PubMed ID: 16915390 [TBL] [Abstract][Full Text] [Related]
12. Isomers of perfluorooctanesulfonate and perfluorooctanoate and total perfluoroalkyl acids in human serum from two cities in North China. Zhang Y; Beesoon S; Zhu L; Martin JW Environ Int; 2013 Mar; 53():9-17. PubMed ID: 23314039 [TBL] [Abstract][Full Text] [Related]
13. [Status of perfluorochemicals in adult serum and umbilical blood in Shenyang]. Jin Y; Liu X; Li T; Qin H; Zhang Y Wei Sheng Yan Jiu; 2004 Jul; 33(4):481-3. PubMed ID: 15461284 [TBL] [Abstract][Full Text] [Related]
14. Perfluorooctane sulfonate and perfluorooctanoic acid in surgical thyroid specimens of patients with thyroid diseases. Pirali B; Negri S; Chytiris S; Perissi A; Villani L; La Manna L; Cottica D; Ferrari M; Imbriani M; Rotondi M; Chiovato L Thyroid; 2009 Dec; 19(12):1407-12. PubMed ID: 20001722 [TBL] [Abstract][Full Text] [Related]
15. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Maestri L; Negri S; Ferrari M; Ghittori S; Fabris F; Danesino P; Imbriani M Rapid Commun Mass Spectrom; 2006; 20(18):2728-34. PubMed ID: 16915561 [TBL] [Abstract][Full Text] [Related]
16. Examining confounding by diet in the association between perfluoroalkyl acids and serum cholesterol in pregnancy. Skuladottir M; Ramel A; Rytter D; Haug LS; Sabaredzovic A; Bech BH; Henriksen TB; Olsen SF; Halldorsson TI Environ Res; 2015 Nov; 143(Pt A):33-8. PubMed ID: 26432473 [TBL] [Abstract][Full Text] [Related]
17. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Ehresman DJ; Froehlich JW; Olsen GW; Chang SC; Butenhoff JL Environ Res; 2007 Feb; 103(2):176-84. PubMed ID: 16893538 [TBL] [Abstract][Full Text] [Related]
18. Levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) in blood samples from different groups of adults living in Greece. Vassiliadou I; Costopoulou D; Ferderigou A; Leondiadis L Chemosphere; 2010 Aug; 80(10):1199-206. PubMed ID: 20619872 [TBL] [Abstract][Full Text] [Related]
19. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Harada K; Koizumi A; Saito N; Inoue K; Yoshinaga T; Date C; Fujii S; Hachiya N; Hirosawa I; Koda S; Kusaka Y; Murata K; Omae K; Shimbo S; Takenaka K; Takeshita T; Todoriki H; Wada Y; Watanabe T; Ikeda M Chemosphere; 2007 Jan; 66(2):293-301. PubMed ID: 16793116 [TBL] [Abstract][Full Text] [Related]
20. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. Harada K; Saito N; Inoue K; Yoshinaga T; Watanabe T; Sasaki S; Kamiyama S; Koizumi A J Occup Health; 2004 Mar; 46(2):141-7. PubMed ID: 15090689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]